patent expiration

Blue background with repeated three-dimensional dollar-sign shapes and the words The Top Line in red and white at the b
Podcast

Patent expirations push biopharma industry toward a tougher 2026

As patent protections expire and growth slows across the industry, only a handful of drugmakers expect bigger gains in 2026.
fourth quarter Q4

Lilly shines in Q4 as peers brace for 2026 slowdown

Mar 11, 2026 3:00pm
Magnifying glass amplifying warning sign over falling stock figures

BridgeBio shares slide on Pfizer's ATTR patent withdrawal

Feb 6, 2026 10:50am
Naoki Okamura

Astellas CEO resists 'rescue BD' as Xtandi patent cliff nears

Jan 15, 2026 10:42am
Business development BD growth business growth

BMS, Merck, Amgen and more face near-term generic woes: Leerink

Nov 13, 2024 10:57am
FTC building

FTC takes aim at 'sham' biopharma patents

Sep 14, 2023 3:55pm